Qube Research & Technologies (QRT)’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $61.4M | Sell |
669,266
-1,752,027
| -72% | -$153M | 0.06% | 430 |
|
|
2026
Q1 | $206M | Buy |
2,421,293
+2,097,037
| +647% | +$187M | 0.23% | 92 |
|
|
2025
Q4 | $25.6M | Sell |
324,256
-2,608,044
| -89% | -$204M | 0.03% | 790 |
|
|
2025
Q3 | $234M | Buy |
2,932,300
+737,222
| +34% | +$62.9M | 0.24% | 73 |
|
|
2025
Q2 | $200M | Sell |
2,195,078
-2,133,455
| -49% | -$195M | 0.2% | 104 |
|
|
2025
Q1 | $406M | Buy |
4,328,533
+1,206,741
| +39% | +$108M | 0.47% | 30 |
|
|
2024
Q4 | $284M | Buy |
3,121,792
+2,242,340
| +255% | +$214M | 0.37% | 37 |
|
|
2024
Q3 | $91.3M | Buy |
+879,452
| New | +$89.6M | 0.13% | 165 |
|
|
2024
Q1 | – | Sell |
-269,795
| Closed | -$21.5M | – | 4505 |
|
|
2023
Q4 | $21.5M | Sell |
269,795
-1,463,639
| -84% | -$110M | 0.04% | 490 |
|
|
2023
Q3 | $123M | Sell |
1,733,434
-214,672
| -11% | -$16.1M | 0.32% | 68 |
|
|
2023
Q2 | $150M | Buy |
1,948,106
+1,170,966
| +151% | +$90.6M | 0.55% | 23 |
|
|
2023
Q1 | $58.4M | Buy |
777,140
+434,764
| +127% | +$32.3M | 0.25% | 68 |
|
|
2022
Q4 | $27M | Sell |
342,376
-296,479
| -46% | -$22.2M | 0.14% | 191 |
|
|
2022
Q3 | $44.9M | Buy |
+638,855
| New | +$50.1M | 0.27% | 84 |
|
|
2022
Q2 | – | Sell |
-341,698
| Closed | -$25.9M | – | 2565 |
|
|
2022
Q1 | $25.9M | Buy |
+341,698
| New | +$27.1M | 0.22% | 107 |
|
|
2021
Q3 | – | Sell |
-301,534
| Closed | -$24.5M | – | 2268 |
|
|
2021
Q2 | $24.5M | Buy |
301,534
+201,863
| +203% | +$16.5M | 0.28% | 65 |
|
|
2021
Q1 | $7.86M | Buy |
99,671
+7,712
| +8% | +$604K | 0.12% | 187 |
|
|
2020
Q4 | $7.86M | Sell |
91,959
-47,010
| -34% | -$3.89M | 0.11% | 197 |
|
|
2020
Q3 | $10.7M | Buy |
138,969
+97,875
| +238% | +$7.46M | 0.15% | 153 |
|
|
2020
Q2 | $3.01M | Buy |
41,094
+33,321
| +429% | +$2.37M | 0.04% | 518 |
|
|
2020
Q1 | $516K | Sell |
7,773
-808
| -9% | -$57K | 0.02% | 557 |
|
|
2019
Q4 | $591K | Buy |
+8,581
| New | +$585K | 0.02% | 869 |
|
|
2019
Q3 | – | Sell |
-11,297
| Closed | -$810K | – | 280 |
|
|
2019
Q2 | $810K | Sell |
11,297
-21,826
| -66% | -$1.55M | 0.19% | 123 |
|
|
2019
Q1 | $2.27M | Buy |
33,123
+5,738
| +21% | +$371K | 0.3% | 74 |
|
|
2018
Q4 | $1.63M | Buy |
27,385
+12,811
| +88% | +$802K | 0.7% | 12 |
|
|
2018
Q3 | $976K | Buy |
14,574
+13,813
| +1,815% | +$920K | 0.13% | 125 |
|
|
2018
Q2 | $49K | Buy |
761
+47
| +7% | +$3.07K | 0.03% | 524 |
|
|
2018
Q1 | $51K | Buy |
+714
| New | +$51.4K | 0.02% | 271 |
|
Other funds holding CL
Qube Research & Technologies (QRT)'s CL Position: Q2 2026 in Review
Qube Research & Technologies (QRT) reduced its Colgate-Palmolive (CL) stake by 72% in Q2 2026, selling an estimated $153M and leaving 669,266 shares worth $61.4M. The position accounts for 0.06% of the portfolio, ranked #430.
Qube Research & Technologies (QRT) first reported a position in CL in Q1 2018 and has held it in 28 quarters since. The position peaked at $406M in Q1 2025. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Qube Research & Technologies (QRT) held 669,266 shares of Colgate-Palmolive worth $61.4M as of Q2 2026.
- Qube Research & Technologies (QRT) sold 1,752,027 Colgate-Palmolive shares in Q2 2026, an estimated $153M.
- Colgate-Palmolive made up 0.06% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #430 holding.
- Qube Research & Technologies (QRT) first reported a position in Colgate-Palmolive in Q1 2018 and has held it in 28 quarters since.
- Qube Research & Technologies (QRT)'s Colgate-Palmolive position peaked at $406M in Q1 2025.
- 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.